MedPath

A randomised controlled clinical study to evaluate the efficacy and quality of life of structured self glucose monitoring in non-insulin treated type 2 diabetes mellitus patients in Japa

Not Applicable
Conditions
type 2 diabetes mellitus
Registration Number
JPRN-UMIN000008480
Lead Sponsor
Keio University school of medicine, Nephrology, endocrinology, and metabolism department
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
80
Inclusion Criteria

Not provided

Exclusion Criteria

Already treated by insulin Already performed SMBG Who cannot perform SMBG by some reason like dementia Pregnant Who have such diseases which affect the values of Hba1c as end-stage renal disease, liver cirrhosis, thyroid disease, and hematological disorders

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
HbA1c after 6 months and 12months
Secondary Outcome Measures
NameTimeMethod
glycoalbumin after 6 months and 12months change of glycoalbumin/HbA1c ratio after 6 months and 12months change of BMI ratio after 6 months and 12months change of QOL after 6 months and 12months frequency and pattern of severe hypoglycemia frequency and pattern of fasting/postprandial hyperglycemia opinions against Accu-Chek® 360 from study subjects and medical stuffs
© Copyright 2025. All Rights Reserved by MedPath